NCT01265602 - Double-blind, Randomized, Vehicle- and Comparator-controlled, Multi-center Trial to Evaluate the Efficacy and Safety of LAS41007 in the Treatment of Actinic Keratosis | Biotech Hunter

Enrollment

889

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions

Actinic Keratosis

Interventions

DRUG

LAS41007

Topical gel, to be applied twice daily (mornings and evenings), for up to 90 days. Generally 0.5 g gel (pea-sized amount of gel) per application will be sufficient to cover an overall area of 25 cm².

DRUG

LASW1510

Topical gel, to be applied twice daily (mornings and evenings), for up to 90 days. Generally 0.5 g gel (pea-sized amount of gel) per application will be sufficient to cover an overall area of 25 cm².

DRUG

vehicle of LAS41007

Topical gel, to be applied twice daily (mornings and evenings), for up to 90 days. Generally 0.5 g gel (pea-sized amount of gel) per application will be sufficient to cover an overall area of 25 cm².

Trial Locations (1)

49377

Almirall Investigational Site, Vechta